ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings
ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.
Benzinga8/7/2026Positive
ICUI
ICU Medical IncNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$4.56B
P/E Ratio
153.37
EPS
$1.19
Beta
0.75
52W High
$192.85
52W Low
$112.50
50-Day MA
$156.07
200-Day MA
$142.07
Dividend Yield
—
Profit Margin
1.39%
Forward P/E
20.88
PEG Ratio
0.10
About ICU Medical Inc
ICU Medical, Inc. develops, manufactures and sells medical devices used in infusion therapy and critical care applications worldwide. The company is headquartered in San Clemente, California.
Fundamentals
| Revenue (TTM) | $2.16B |
| Gross Profit (TTM) | $845.14M |
| EBITDA | $345.02M |
| Operating Margin | 11.00% |
| Return on Equity | 1.41% |
| Return on Assets | 2.22% |
| Revenue/Share (TTM) | $87.13 |
| Book Value | $86.05 |
| Price-to-Book | 2.13 |
| Price-to-Sales (TTM) | 2.11 |
| EV/Revenue | 2.568 |
| EV/EBITDA | 19.52 |
| Quarterly Earnings Growth (YoY) | -46.90% |
| Quarterly Revenue Growth (YoY) | 0.50% |
| Shares Outstanding | $25.01M |
| Float | $24.54M |
| % Insiders | 1.84% |
| % Institutions | 116.28% |
Historical Volatility
HV 10-Day
58.92%
HV 20-Day
44.90%
HV 30-Day
43.16%
HV 60-Day
39.07%
HV Rank
87.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($193.38 target)
3
Strong Buy4
Buy1
HoldLatest News
ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript
ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript
Seeking Alpha8/7/2026Neutral
ICU Medical Q2 Earnings Call Highlights
ICU Medical NASDAQ: ICUI reported second-quarter revenue of $548 million, up 6% organically and 1% on a reported basis, as growth in its consumables and infusion systems businesses helped offset continued pressure in Vital Care and the effects of the IV Solutions joint venture deconsolidation.
MarketBeat8/7/2026Positive
ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
SAN CLEMENTE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2026.
GlobeNewsWire8/6/2026Neutral
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
SAN CLEMENTE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2026 earnings release and conference call.
GlobeNewsWire7/23/2026Neutral
Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America
This expansion of IV solutions manufacturing will help enhance supply-chain resiliency, support portfolio development and advance non-DEHP innovation for the North American IV solutions market. Joint venture announces over $500M IV solutions manufacturing expansion in Austin, TX Expansion aimed at improving IV solutions supply resiliency and quality, and accelerating non-DEHP new product development in North America via fully automated technology First major milestone toward fulfilling the commitments of the joint venture finalized in May 2025 between ICU Medical, Inc. and Otsuka Pharmaceutical Factory America, Inc. AUSTIN, Texas, July 9, 2026 /PRNewswire/ -- Otsuka ICU Medical LLC today announced plans for an over $500 million expansion to its US IV solutions manufacturing through a new facility and significant upgrades to its existing operations in Austin, Texas.
PRNewsWire7/9/2026Neutral
ICUI vs. SYK: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Products sector might want to consider either ICU Medical (ICUI) or Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
Zacks Investment Research7/8/2026Positive
ICUI or MDLN: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Products sector might want to consider either ICU Medical (ICUI) or Medline (MDLN). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks Investment Research6/18/2026Positive
ICU Medical's General Counsel Sells — The Smiths Integration Is Almost Done, the Proof Isn'tICU Medical's General Counsel Sells — The Smiths Integration Is still playing out.
2,447 shares sold for a transaction value of ~$304,000. This sale represented 11.17% of Sanzone's direct holdings.
The Motley Fool6/10/2026Neutral
Implied Volatility Surging for ICU Medical Stock Options
Investors need to pay close attention to ICUI stock based on the movements in the options market lately.
Zacks Investment Research5/8/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ICUI and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 8/18/2026